應用於炭疽芽孢桿菌檢測套件
K 號：K183462 · 2019-10-01
廣告
申請人Mriglobal
決定日期2019-10-01
產品代碼QIF
諮詢委員會此醫療器材為一項用於治療[疾病名稱]之裝置，已通過美國食品藥物管理局（FDA）之510(k)上市前通知程序，並取得[產品名稱]之上市許可。本裝置亦已獲得PMA（上市前核准）之認可，相關臨床試驗資料已登錄於ClinicalTrials.gov（NCT編號：[NCT號碼]），並已發表於經同儕審查之醫學期刊（PMID：[PMID號碼]）。更多詳細資訊請參閱：[URL]。
決定相當於
器材摘要
Applied Biosystems Bacillus anthracis Detection Kit is the device name listed in this FDA 510(k) record. The listed applicant is Mriglobal. It received FDA 510(k) clearance on 2019-10-01 under 510(k) number K183462. The device is classified under product code QIF. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.
常見問題
What is the Applied Biosystems Bacillus anthracis Detection Kit?
Applied Biosystems Bacillus anthracis Detection Kit is a medical device that received FDA 510(k) clearance on 2019-10-01. The listed applicant is Mriglobal. The 510(k) number is K183462.
When did Applied Biosystems Bacillus anthracis Detection Kit receive FDA 510(k) clearance?
Applied Biosystems Bacillus anthracis Detection Kit received FDA 510(k) clearance on 2019-10-01, under 510(k) number K183462.
Who is the listed applicant for Applied Biosystems Bacillus anthracis Detection Kit?
The FDA 510(k) record lists Mriglobal as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Applied Biosystems Bacillus anthracis Detection Kit?
The FDA product code for Applied Biosystems Bacillus anthracis Detection Kit is QIF.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告